Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH
    • 804 complaints of...

    804 complaints of misleading advertisements of Ayurvedic, herbal products in 2 years

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2018-02-11T10:00:14+05:30  |  Updated On 11 Feb 2018 10:00 AM IST
    804 complaints of misleading advertisements of Ayurvedic, herbal products in 2 years

    804 complaints of misleading advertisements of Ayurvedic, herbal products have been registered in the last two years, the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Lok Sabha informed .


    Increasing number of alleged to be misleading advertisements of Ayurvedic and other such products are being reported. Ministry of AYUSH has come across 804 instances of misleading advertisements/claims allegedly of herbal/AYUSH products & services including Ayurvedic medicines during the period of last two years and current year from April, 2015 to January, 2018 as reported from the Advertising Standards Council of India (ASCI) and the Grievances Against Misleading Advertisements (GAMA) portal maintained by the Department of Consumer Affairs.


    it is true that there has been no exclusive definition of herbal medicines in the Drugs & Cosmetics Act, 1940 and Rules thereunder. But with effect from 30th November 2015 a new category of drugs derived from herbal materials or medicinal plants called as “Phytopharmaceutical drugs” has been included under Rule 2(eb) of the Drugs and Cosmetics Rules, 1945 to provide regulatory provisions for such drugs made from purified and standardized fraction with defined minimum four bio-active or phytochemical compounds of an extract of a medicinal plant or its part.


    As such there is no legislative lacuna for the advertisement of herbal medicines/products since the definition of ‘drug’ given in the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 covers all medicines, substances and articles other than food. For checking the veracity and to undertake monitoring of misleading advertisements, powers are vested with the State Governments to authorize Gazetted Officers to search, seize, examine any record, register, document or any other material object related to any objectionable advertisement under the provisions of Section 8(1) of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.


    Ministry of AYUSH has repeatedly taken up the matter with the State Governments to appoint Gazetted officers for monitoring of advertisements of AYUSH drugs and it is reported that 22 States have appointed 621 Gazetted officers to enforce the legal provisions for taking necessary action against the defaulters. Ministry of AYUSH also signed a MoU with Advertising Standards Council of India (ASCI) for suo-moto monitoring of misleading advertisements of AYUSH drugs appearing in the print media and TV channels and bring the defaulters to the notice of respective State regulators.


    Media regulators have also been approached to prevent the publication of inappropriate advertisements promoting the sale of Ayurvedic and other AYUSH medicines in public interest. On this account, Ministry of Information & Broadcasting has issued instructions/guidelines dated 12th July, 2017 to all media channels to advertise only those products which have valid manufacturing license and to abstain from telecasting such misleading advertisements which are in contravention of the provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and Rules thereunder.


    Consumers’ complaints about misleading claims or advertisements of AYUSH and herbal medicines registered in the GAMA (Grievances Against Misleading Advertisements) portal of the Department of Consumer Affairs are examined by a Nodal Officer appointed in the Ministry of AYUSH and are forwarded to the concerned State Regulatory Authorities for necessary action in accordance with the legal provisions.

    Advertising Standards Council of IndiaDepartment of Consumer AffairsDrugs and Cosmetics ActDrugs and Magic RemediesLok SabhaMinistry of Ayushmisleading advertisementsPhytopharmaceutical drugsShripad Yesso Naik
    Source : government press release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok